维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Steg AD"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Glil enhances migra- tion and invasion via up-regulation of MMP-11 and pro- motes metastasis in ERalpha negative breast cancer cell lines 显示文摘	Kwon YJ Hurst DR Steg AD	2011	Clin Exp Metastasis2011，28，5：	1
2	Smoothened antagonists reverse taxane resistance in ovarian cancer显示文摘	Steg AD Katre AA Bevis KS	2012	Mol Cancer Ther2012，11，7：	1
3	Stem cell pathways contribute to clinical chemoresistance in ovarian cancer显示文摘	Steg AD Bevis KS Katre AA	2012	Clin Cancer Res2012，18，3：	1
4	Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer显示文摘	Steg AD Katre AA Goodman B		0，，17：	1
5	Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer显示文摘	Steg AD Katre AA Goodman B	2011	Clin Cancer Res2011，17，17：	1
6	Glil enhances mi- gration and invasion via up-regulation of MMP-11 and promotes metastasis in ERa negative breast cancer cell lines显示文摘	Kwon YJ Hurst DR Steg AD	2011	Clin Exp Metastasis2011，28，5：	1
7	Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian eancer显示文摘	Dobbin ZC Katre AA Steg AD	2014	Oneotarget2014，5，18：	1
8	Stem cell pathways contribute to clinical chemoresistance in ovarian can-cer显示文摘	Steg AD Bevis KS Katre AA		0，，03：	1
9	Stem cell pathways contribule to clinical chemoresistance in ovarian cancer 显示文摘	Steg AD Bevis KS Katre AA	2012	Clin Cancer Res2012，18，3：	1
10	Differential expression of breast cancer-associated genes between stage-and age-matched tumor specimens from African-and Caucasian-American Women diagnosed with breast cancer显示文摘	Grunda JM Steg AD He Q	2012	BMC Res Notes2012，5，：	1
11	( CD105 ) contrib- utes to platinum resistance and is a target for tumor - spe- cific therapy in epithelial ovarian cancer 显示文摘	Ziebarth AJ Nowsheen S Steg AD	2013	Clin Cancer Res2013，19，1：	1
12	Stem cell pathways contri- bute to clinical chemoresistance in ovarian cancer 显示文摘	Steg AD Bevis KS Katre AA et ol	2012	Clin Cancer Res2012，18，3：	1
13	Glil enhances migration and invasion via up-regulation of MMP-II and promotes metastasis in ERa negative breast cancer cell lines显示文摘	Kwon YJ Hurst DR Steg AD	2011	Clin Exp Metastasis2011，28，5：	1
14	Targeting the notch lig and JAGGED1 in both tumor cells and stroma in ovariancancer 显示文摘	Steg AD Katre AA Goodman B	2011	Clin Cancer Res2011，17，17：	1
15	Stem cell pathways contribute to clinical chemoresistance in ovarian cancer 显示文摘	Steg AD Bevis KS Katre AA	2012	Clin Cancer Res2012，18，3：	1
16	Smoothened antagonists reverse taxane resistance in ovarian cancer 显示文摘	Steg AD Katre AA Bevis KS	2012	Mol Cancer Ther2012，11，7：	1
17	Stem cell pathways contribute to clinical chemoresistance in ovarian cancer显示文摘	Steg AD Bevis KS Katre AA	2012	Clin Cancer Res2012，18，3：	1
18	Endoglin (CD105)contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer显示文摘	Ziebarth AJ Nowsheen S Steg AD	2013	Clin Cancer Res2013，19，1：	1
19	Proteasome inhibition re- verses hedgehog inhibitor and taxane resistance in ovarian cancer 显示文摘	Steg AD Burke MR Amm HM	2014	Oncotarget2014，5，16：	1
20	Gill enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERalpha negative breast cancer cell lines显示文摘	Kwon Y J Hurst DR Steg AD	2011	Clin Exp Metas- tasis2011，28，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示